^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Capesaris (GTx-758)

    i
    Other names: GTx-758
    Associations

    News

    Trials
    Company:
    Oncternal Therap
    Drug class:
    Estrogen receptor agonist
    Related drugs:
    Associations

    News

    Trials
    over4years
    Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate Cancer. (PubMed, Clin Genitourin Cancer)
    GTx-758 has clinical activity for CRPC in a dose-dependent fashion. GTx-758 resulted in a reduction in hot flashes. On the basis of these findings, further clinical investigation of novel estrogen therapies is warranted.
    P2 data • Journal
    |
    ER (Estrogen receptor)
    |
    Capesaris (GTx-758)